JA

Jenna Abelli

CEO of Sofregen

Greater Boston

Overview 

Jenna Abelli is currently serving as the CEO of Sofregen and as a Principal at Anzu Partners in Greater Boston. With a background in engineering and a strong focus on material science, medical devices, and biotech sectors, she has successfully led Sofregen and invested in companies like CytoTronics at various stages of development.

Work Experience 

SI

Sofregen Inc.

  • President & Chief Executive Officer

    2023 - Current

AR

Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA

  • Advisory Board Member

    2023

    BioFab Startup Lab

Advanced Regenerative Manufacturing Institute is a member-based nonprofit organization.

Raised $44,000,000.00 from US Department of Commerce, Economic Development Administation.

armiusa.org
AP

Anzu Partners

  • Principal

    2018

    Anzu Partners is a venture capital and private equity firm that invests in breakthrough industrial technologies. We team with entrepreneurs to develop and commercialize technological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. https://www.anzupartners.com/

Anzu Partners is an investment firm that invests in industrial and life science technology companies.

anzupartners.com
C

CytoTronics

  • Board Member

    2021

    CytoTronics is disrupting the traditional drug discovery process through a highly differentiated engineering approach. Spinning out from Harvard after a decade of research, our proprietary semiconductor-cell interface can deliver high-dimensional functional assessment of live-cell responses at scale. CytoTronics’ platform integrates the semiconductor-cell interface, live-cell biology, and machine learning, to generate more translational insights earlier in the drug discovery process, unlocking previously undruggable diseases.

CytoTronics is designing and developing cell culture plates with embedded high-density electronic systems.

Raised $22,750,000.00 from RIT Venture Fund I, LLC, Legend Star, Anzu Partners, BoxOne Ventures, LYFE Capital, Draper Associates, Anzu Partners and Milad Alucozai.

cytotronics.com
BI

BioFlyte, Inc.

  • Board Member

    2022

    BioFlyte® is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security.

BioFlyte is a biodefense company that commercializes a new class of fieldable biological threat collection.

Raised $12,750,000.00 from Scout Ventures, Cottonwood Technology Fund, New Mexico Vintage Fund and Scout Ventures.

bioflyte.com
CM

Cascade Maverik Lacrosse, LLC

  • Senior Brand & Product Manager, Women's Lacrosse

    2014 - 2018

C

Continental

  • Project Leader Tire Line Development

    2010 - 2014

  • Advanced Development Programs

    2010 - 2013

    Market Development in MENA (Hannover, Germany) Parts Complexity Reduction in Manufacturing (Lousado, Portugal) eXplore R&D Program (Hannover, Germany)

Continental Tire is a manufacturer of tires for motor vehicles.

continentaltire.com
UE

U.S. Environmental Protection Agency

  • Physical Science Technician

    2009 - 2010

EPA is an independent executive agency aiming to protect human health and the environment.

Raised $400,000.00.

epa.gov

Education 

Investments 

CytoTronics

Seed

Total funding: $9M

Articles About Jenna

Relevant Websites